Valuation: RAMM Pharma Corp.

Market Cap 11.94L 9L 7L 7L 6L 8.18Cr 11.99L 84.06L 32.44L 4.16Cr 32.02L 31.3L 13Cr P/E 2024
-0.07x
P/E 2025 -0.2x
Enterprise Value 5L 3L 3L 3L 3L 3.22Cr 5L 33.12L 12.78L 1.64Cr 12.61L 12.33L 5.27Cr EV / Sales 2024
0.13x
EV / Sales 2025 0.32x
Free-Float
68.57%
Yield 2024 *
-
Yield 2025 -
1 day+100.00%
1 week+100.00%
Current month+100.00%
3 months-33.33%
6 months-33.33%
Current year-83.33%
1 week 0.01
Extreme 0.01
0.01
1 month 0
Extreme 0.005
0.01
Current year 0
Extreme 0.005
0.05
1 year 0
Extreme 0.005
0.25
3 years 0
Extreme 0
0.25
5 years 0
Extreme 0
0.6
10 years 0
Extreme 0
1.19
Manager TitleAgeSince
Chief Executive Officer - 01/10/2019
Director of Finance/CFO - 09/12/2022
Director TitleAgeSince
Director/Board Member - 01/10/2019
Director/Board Member 82 01/10/2019
Director/Board Member 66 01/10/2019
Date Insider Type Main position Quantity % Market Cap. Importance
02/06/25 Sell

Chief Executive Officer

46,67,000 3.9091%
21/03/25 Buy

Chief Executive Officer

2,00,000 0.1675%
21/03/25 Buy

Chief Executive Officer

1,00,000 0.0838%
Change 5-day change 1-year change 3-year change Capi.($)
+100.00%+100.00%-33.33%-90.00% 9L
+0.04%+3.34%+53.32%+100.52% 1,02800Cr
-0.09%+1.66%+53.24%+66.45% 65TCr
-0.02%+2.66%+18.65%+71.97% 47TCr
-1.22%+3.66%+34.59%+38.81% 35TCr
-0.79%+2.73%+17.73%+25.11% 27TCr
+0.58%+6.76%+10.58%+17.75% 26TCr
+1.55%+2.20%+35.12%+45.91% 21TCr
+0.79%+1.84%-27.55%-56.48% 19TCr
-0.52%+4.45%+31.57%+98.11% 19TCr
Average +10.03%+2.93%+19.39%+31.81% 36.02TCr
Weighted average by Cap. -0.04%+3.09%+34.84%+61.60%

Financials

2024 2025
Net sales 43.42L 31L 27.03L 25.52L 23.17L 30Cr 43.6L 3.06Cr 1.18Cr 15Cr 1.16Cr 1.14Cr 49Cr 33.61L 23.99L 20.92L 19.75L 17.94L 23Cr 33.75L 2.37Cr 91.31L 12Cr 90.12L 88.12L 38Cr
Net income -1.65Cr -1.18Cr -1.03Cr -96.99L -88.08L -113.04Cr -1.66Cr -12Cr -4.48Cr -57Cr -4.43Cr -4.33Cr -184.91Cr -89.1L -63.6L -55.46L -52.37L -47.56L -61Cr -89.47L -6.27Cr -2.42Cr -31Cr -2.39Cr -2.34Cr -100Cr
Net Debt -6L -4L -4L -4L -3L -4.29Cr -6L -44.05L -17L -2.18Cr -16.78L -16.41L -7.01Cr -7L -5L -5L -4L -4L -4.96Cr -7L -50.94L -19.66L -2.52Cr -19.4L -18.97L -8.11Cr
Logo RAMM Pharma Corp.
RAMM Pharma Corp. is a Canada-based company that is primarily engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. It has multiple approved and registered products that have been authorized for sale, as well as other products in various stages of development. The Company also operates GMP certified cannabis formulation facilities in Uruguay and Poland to ensure their products are compliant with the standard and address international markets. The Company owns and operates a medical services business in Uruguay and a cosmetic and nutraceutical business in the European Union. The Company's brands include Medic Plast, Nettalife, Canapar, and Marishanti. Its subsidiaries include Medic Plast S.A., Yurelan S.A., RAMM Pharma Holdings Corp., Canapar Corp, and Hempoland S.p.a Z.o.o.
Employees
-
Date Price Change Volume
16/26/16 CA$0.0100 +100.00% 50,000
11/26/11 CA$0.005000 0.00% 5,000
  1. Stock Market
  2. Stocks
  3. RAMM Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!